Document Detail


Crystal structure-based selective targeting of the pyridoxal 5'-phosphate dependent enzyme kynurenine aminotransferase II for cognitive enhancement.
MedLine Citation:
PMID:  20684605     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fluctuations in the brain levels of the neuromodulator kynurenic acid may control cognitive processes and play a causative role in several catastrophic brain diseases. Elimination of the pyridoxal 5'-phosphate dependent enzyme kynurenine aminotransferase II reduces cerebral kynurenic acid synthesis and has procognitive effects. The present description of the crystal structure of human kynurenine aminotransferase II in complex with its potent and specific primary amine-bearing fluoroquinolone inhibitor (S)-(-)-9-(4-aminopiperazin-1-yl)-8-fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-azaphenalene-5-carboxylic acid (BFF-122) should facilitate the structure-based development of cognition-enhancing drugs. From a medicinal chemistry perspective our results demonstrate that the issue of inhibitor specificity for highly conserved PLP-dependent enzymes could be successfully addressed.
Authors:
Franca Rossi; Casazza Valentina; Silvia Garavaglia; Korrapati V Sathyasaikumar; Robert Schwarcz; Shin-Ichi Kojima; Keisuke Okuwaki; Shin-Ichiro Ono; Yasushi Kajii; Menico Rizzi
Related Documents :
9675245 - Interaction of phosphonomethyl analog of dihydroxyacetone phosphate with rabbit muscle ...
11965 - Properties of rat kidney glutaminase enzymes and their role in renal ammoniagenesis.
4298815 - Production of phosphatase by aspergillus awamori var. kawachii in a low phosphate medium.
7622485 - Purification and characterization of a small membrane-associated sugar phosphate phosph...
8836125 - Immunocytochemical localization and biochemical characterization of a novel plasma memb...
24875315 - Characterization and cdna sequence of bothriechis schlegelii l-amino acid oxidase with ...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of medicinal chemistry     Volume:  53     ISSN:  1520-4804     ISO Abbreviation:  J. Med. Chem.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-05     Completed Date:  2010-09-08     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  9716531     Medline TA:  J Med Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5684-9     Citation Subset:  IM    
Data Bank Information
Bank Name/Acc. No.:
PDB/2XH1
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Brain / drug effects,  enzymology
Crystallography, X-Ray
Fluoroquinolones / chemistry*,  pharmacology
Humans
Models, Molecular
Nootropic Agents / chemistry*,  pharmacology
Piperazines / chemistry*,  pharmacology
Protein Conformation
Pyridoxal Phosphate / physiology*
Stereoisomerism
Transaminases / antagonists & inhibitors,  chemistry*
Grant Support
ID/Acronym/Agency:
NS25296/NS/NINDS NIH HHS; R01 NS025296/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/9-(4-aminopiperazin-1-yl)-8-fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-azaphenalene-5-carboxylic acid; 0/Fluoroquinolones; 0/Nootropic Agents; 0/Piperazines; 5V5IOJ8338/Pyridoxal Phosphate; EC 2.6.1.-/Transaminases; EC 2.6.1.7/kynurenine-oxoglutarate transaminase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of...
Next Document:  Synthesis and in Vivo Evaluation of Phenethylpiperazine Amides: Selective 5-Hydroxytryptamine(2A) Re...